Home » Abstract Submission

Abstract Submission

The abstract submission deadline is January 15, 2027, at 11:59 PM CET

For the first time ever the program will feature a COPHy Flash Talks session. The top 8 abstract submissions will be chosen for a premier spotlight—with presenters delivering a high-impact 5-minute flash talk in the main plenary hall, followed by 2 minutes of Q&A (no debate).

If you are willing to deliver a short talk, in addition to your ePoster, please indicate this by selecting the presentation type: ePoster & Short Talk.

The Review Committee reserves the right to select the ePoster abstracts for a short talk.

IMPORTANT: All abstracts will be considered for ePoster display.

* Maximum 2 abstracts per presenting author.

 List of Topics

  •  Medical Retina
  •  Surgical Retina
  •  Neuro-Ophthalmology
  • Uveitis
  • Glaucoma
  • Anterior Segment
  • Pediatric Ophthalmology

Before you begin, please prepare the following information:

  •  Title of the abstract and chosen topic
  •  Family names and initials of all authors
  •  Details of affiliation of all author(s); institution, city, country
  •  Contact details of the presenting author (email, mobile phone)

Important note: Abstracts should not exceed 250 words and no images/graphs/tables etc. are allowed.

About abstract submission:

ALL SUBMITTED ABSTRACTS MUST BE IN ENGLISH AND FOLLOW THE STRUCTURED FORMAT BELOW:

Title

Purpose

Methods

Results

Conclusions

Be sure that all changes, corrections and proofreading have been carried out before submitting.

Please note: You will be able to update and/or make changes to your submitted abstract until the submission deadline date, using your email address and password which will be provided for you upon completing your submission.

If you have any questions, please contact the secretariat at cophy@comtecint.com, mentioning your name and abstract title.

Cookie settings
We value your privacy
We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy